Mutations in two genes, IDH1 and IDH2, might provide markers that enable doctors to discern malignant from benign brain tumors and catch some cancers early, scientists report in the Feb.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.